Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Samuel R Schnittman und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Coronary Artery Disease, Cardiovascular Diseases, Cytomegalovirus Infections, HIV Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIA NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Cytomegalovirus (CMV) infection is thought to result in increased immune activation in people with human immunodeficiency virus (HIV, PWH). Although some data have linked asymptomatic CMV infection to cardiovascular disease among PWH, it remains unknown whether CMV is associated with increased or high-risk coronary plaque.
Methods
The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) enrolled PWH aged 40–75 years on stable antiretroviral therapy (ART) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk. Among a subset of US REPRIEVE participants, coronary plaque was assessed by coronary computed tomography angiography. Here, we assessed the relationship between CMV immunoglobulin G (IgG) titer and (1) levels of immune activation, (2) inflammatory biomarkers, and (3) coronary plaque phenotypes at study entry.
Results
Of 672 participants, mean age was 51 years, 83% were men, median ASCVD risk score was 4.5%, and 66% had current CD4+ T-cell count ≥500 cells/mm3. Higher CMV IgG quartile group was associated with older age and lower current and nadir CD4+ T-cell counts. CMV IgG titer was associated with specific inflammatory biomarkers (sCD163, MCP-1, interleukin [IL]-6, hsCRP) in univariate analysis, but not after controlling for HIV-specific factors. In contrast, CMV IgG titer was not associated with coronary artery disease indexes, including presence of plaque, coronary artery calcium (CAC) score >0, vulnerable plaque presence, or Leaman score >5.
Conclusions
No meaningful association was seen between CMV IgG titer and coronary artery disease indexes among ART-treated PWH at study enrollment. Longitudinal assessments in REPRIEVE will determine the relationship of CMV IgG titer to plaque progression and cardiovascular events. Clinical Trials Registration NCT02344290.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
- School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany.
- Department of Microbiology, Immunology, and Inflammation and Center for Neuro-Virology and Gene Editing, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.
- Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
ORCID-Profile: Samuel R Schnittman, Borek Foldyna, Carlos Malvestutto, Steven K Grinspoon
Förderung
- NIAID NIH HHS
- NIA NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- REPRIEVE Clinical Coordinating Center
- REPRIEVE Data Coordinating Center
Zitieren
APA
Schnittman, S. R., Lu, M. T., Mayrhofer, T., Burdo, T. H., Fitch, K. V., McCallum, S., Fulda, E. S., Zanni, M. V., Foldyna, B., Malvestutto, C., Fichtenbaum, C. J., Aberg, J. A., Bloomfield, G. S., Overton, E. T., Currier, J., Tebas, P., Sha, B. E., Ribaudo, H. J., Flynn, J. M., …, & Grinspoon, S. K. (2023). Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac662
Vancouver
Schnittman SR, Lu MT, Mayrhofer T, Burdo TH, Fitch KV, McCallum S, et al. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac662
BibTeX
@article{Schnittman2023,
author = {Schnittman, Samuel R and Lu, Michael T and Mayrhofer, Thomas and Burdo, Tricia H and Fitch, Kathleen V and McCallum, Sara and Fulda, Evelynne S and Zanni, Markella V and Foldyna, Borek and Malvestutto, Carlos and Fichtenbaum, Carl J and Aberg, Judith A and Bloomfield, Gerald S and Overton, Edgar T and Currier, Judith and Tebas, Pablo and Sha, Beverly E and Ribaudo, Heather J and Flynn, Jacqueline M and Douglas, Pamela S and Erlandson, Kristine M and Grinspoon, Steven K},
title = {Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac662}
}
EUVIMED